Europe — EMA
Metazydyna (Trimetazidine Dihydrochloride)
GNH USA supplies Metazydyna (Trimetazidine), a anti‑ischemic metabolic agent for angina pectoris, chronic coronary artery disease and peripheral arterial
Request sourcing
What is Trimetazidine Dihydrochloride?
Trimetazidine dihydrochloride, the active ingredient in Metazydyna, is an anti‑ischemic metabolic agent presented as an oral tablet for oral use. It is used to manage angina pectoris and related ischemic heart conditions in adults.
GNH USA supplies Metazydyna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Trimetazidine Dihydrochloride used for?
Metazydyna is indicated for conditions involving myocardial ischemia and peripheral arterial insufficiency.
- Angina pectoris: reduces the frequency and severity of chest pain episodes by improving myocardial energy efficiency. - Chronic coronary artery disease: helps stabilize symptoms and may improve exercise tolerance. - Peripheral arterial disease: supports tissue perfusion by enhancing cellular metabolism in ischemic limbs.
What are the side effects of Trimetazidine Dihydrochloride?
Trimetazidine is generally well tolerated, but adverse reactions can occur.
Common Side Effects: - Nausea - Headache - Dizziness - Gastrointestinal discomfort - Constipation - Fatigue
Serious or Rare Side Effects: - Severe allergic reactions (e.g., rash, angioedema) - Liver enzyme elevation - Thrombocytopenia - Extrapyramidal symptoms - Significant hypotension - Arrhythmias
What precautions apply to Trimetazidine Dihydrochloride?
Use of Metazydyna requires careful clinical assessment and monitoring.
- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic dysfunction: use with caution and observe liver enzymes. - Elderly patients: watch for dizziness or orthostatic symptoms. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Concomitant anti‑anginal therapy: assess for additive hemodynamic effects. - Store at below 25°C: keep in the original pack, protect from moisture.
What does Trimetazidine Dihydrochloride interact with?
Trimetazidine may interact with several drug classes; monitoring is advised.
Major Interactions (Avoid): - Dopamine antagonists (e.g., metoclopramide): increased risk of extrapyramidal reactions. - Other potent anti‑ischemic agents causing severe hypotension.
Moderate Interactions (Monitor Closely): - Antihypertensive drugs: monitor blood pressure for additive lowering. - Diuretics: watch electrolyte balance and renal function. - Other metabolic modulators: observe for enhanced gastrointestinal effects.



